Envision Healthcare Co. (EVHC) Shares Sold by Sectoral Asset Management Inc
Sectoral Asset Management Inc lowered its holdings in shares of Envision Healthcare Co. (NYSE:EVHC) by 14.7% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 113,600 shares of the company’s stock after selling 19,620 shares during the period. Sectoral Asset Management Inc owned about 0.09% of Envision Healthcare worth $5,106,000 as of its most recent SEC filing.
Other hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in shares of Envision Healthcare by 1.8% in the 2nd quarter. Vanguard Group Inc. now owns 11,471,402 shares of the company’s stock valued at $718,912,000 after purchasing an additional 204,584 shares in the last quarter. BlackRock Inc. raised its holdings in Envision Healthcare by 2.1% in the 2nd quarter. BlackRock Inc. now owns 7,345,283 shares of the company’s stock worth $460,330,000 after purchasing an additional 147,652 shares in the last quarter. Maverick Capital Ltd. raised its holdings in Envision Healthcare by 66.2% in the 2nd quarter. Maverick Capital Ltd. now owns 5,093,292 shares of the company’s stock worth $319,197,000 after purchasing an additional 2,028,026 shares in the last quarter. Janus Henderson Group PLC raised its holdings in Envision Healthcare by 36,086.8% in the 2nd quarter. Janus Henderson Group PLC now owns 3,945,087 shares of the company’s stock worth $247,239,000 after purchasing an additional 3,934,185 shares in the last quarter. Finally, OZ Management LP bought a new position in shares of Envision Healthcare in the 3rd quarter worth about $131,987,000.
Envision Healthcare Co. (EVHC) traded up $0.67 on Friday, hitting $31.20. 2,295,800 shares of the company were exchanged, compared to its average volume of 2,240,959. The company has a debt-to-equity ratio of 0.89, a quick ratio of 3.00 and a current ratio of 3.01. The stock has a market capitalization of $3,690.75, a P/E ratio of 9.42, a price-to-earnings-growth ratio of 0.79 and a beta of 0.57. Envision Healthcare Co. has a one year low of $23.77 and a one year high of $73.00.
Envision Healthcare (NYSE:EVHC) last posted its quarterly earnings data on Tuesday, October 31st. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.08). The business had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $2.03 billion. Envision Healthcare had a positive return on equity of 4.88% and a negative net margin of 6.39%. The business’s quarterly revenue was up 142.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.13 EPS. research analysts predict that Envision Healthcare Co. will post 2.57 EPS for the current fiscal year.
Envision Healthcare declared that its board has initiated a share repurchase program on Monday, September 18th that allows the company to repurchase $250.00 million in outstanding shares. This repurchase authorization allows the company to buy up to 4.5% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s management believes its stock is undervalued.
EVHC has been the topic of several recent analyst reports. Robert W. Baird reissued a “buy” rating and set a $70.00 price objective on shares of Envision Healthcare in a research report on Tuesday, October 17th. SunTrust Banks set a $55.00 price objective on shares of Envision Healthcare and gave the company a “buy” rating in a research report on Sunday, October 15th. Bank of America cut their price objective on shares of Envision Healthcare from $72.00 to $60.00 and set a “buy” rating on the stock in a research report on Monday, October 9th. Jefferies Group set a $71.00 price objective on shares of Envision Healthcare and gave the company a “buy” rating in a research report on Thursday, August 24th. Finally, KeyCorp set a $67.00 price objective on shares of Envision Healthcare and gave the company a “buy” rating in a research report on Wednesday, November 1st. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $47.57.
WARNING: “Envision Healthcare Co. (EVHC) Shares Sold by Sectoral Asset Management Inc” was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/envision-healthcare-co-evhc-shares-sold-by-sectoral-asset-management-inc/1751637.html.
Envision Healthcare Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Co. (NYSE:EVHC).
Receive News & Ratings for Envision Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.